nasopharyngeal cancerradiationprognostic markersmicro-arraysrobotic screensNasopharyngeal carcinoma (NPC) is a unique malignant epithelial carcinoma of the head-and-neck region, with unique viral biology and geographic distributions in the world. Significant advances have been made in the clinical therapies ...
Cervical Cancer宫颈癌-中英文 ·CervicalCancer Cervicalcancer •Etiology（病因）:HPV•Diagnosis（诊断）:biopsy,stage•Theraphy（治疗）:surgeryandradiation•Prevention（预防）CERVICALCANCER...•Themostcommonmalignancy（恶性肿瘤）ingynecologicaloncology •Incidence（发病率）:7.8/100,000（我国每年新发...
Cervical cancer remains one of the greatest killers of women worldwide. It is difficult to foresee a dramatic increase in cure rate even with the most optimal combination of cytotoxic drugs, surgery, and radiation; therefore, testing of molecular targete
宫颈癌FIGO分期ⅢC期诊治的研究进展 陈博 川北医学院 摘要: 肿瘤的分期对指导治疗及判断预后具有重要的意义。2018年国际妇产科联盟(FIGO)发布了新的宫颈癌分期标准,首次将盆腔及腹主动脉旁淋巴结转移纳入分期,并单独归为ⅢC期。目前就淋巴结转移直接归为ⅢC期的合理性存在争议,影像学检查的判定缺乏统一标准,该期...
Prognostic effect of different cut-off values (20mm, 30mm and 40mm) for clinical tumor size in FIGO stage IB cervical cancer ObjectiveThe aim of this study is to evaluate whether applying cut-off values of 20mm, 30mm and 40mm for tumor size have prognostic value in terms of survi... T ...
FIGO 2018 stage IB2 (2–4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study International...
Cervical Cancer宫颈癌-中英文.ppt,2014 FIGO 分期 Clinical Staging for Cervical Carcinoma Stage I Invasion is strictly confined to the cervix IA: Invasive cancer identified only microscopically . IA1: Minimal microscopically evident stromal invasion =3mm i
S-1 plus cisplatin may provide some benefit as first-line chemotherapy for patients with FIGO stage IVB, recurrent, or persistent cervical cancer in terms of PFS and ORR compared with cisplatin alone, although contribution to survival is unclear. Given that the standard therapy for this population...
“Today’s approval of KEYTRUDA plus chemoradiotherapy is welcome news and gives patients with newly diagnosed FIGO 2014 Stage III-IVA cervical cancer, for the first time ever, the option of an anti-PD-1-based regimen to treat their cancer,” ...
cervical cancer.Methods and MaterialsPatients with FIGO Stage IB–IIIB cervical cancer received 70 tandem HDR applications using CT-based treatment planning. ... L Lee,C Sadow,A Russell,... - 《Brachytherapy》 被引量: 212发表: 2009年 A Phase II Comparative Study of Gross Tumor Volume Definit...